EMEA Blood Glucose Monitoring Market Research Report Information, By Product Types (Invasive Glucose Monitoring, CGM, Flash Glucose Monitoring), Applications (Type 1 Diabetes, Type 2 Diabetes), and End Users (Diagnostic Centers, Hospitals, Clinics) - Forecast till 2032

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. EMEA Blood Glucose Monitoring Market, by Product Type

6.1 Introduction

6.2 Invasive Glucose Monitoring Devices

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Continuous Glucose Monitoring Devices

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Flash Glucose Monitoring Devices

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Others

7. EMEA Blood Glucose Monitoring Market, by Application

7.1 Introduction

7.2 Type 1 Diabetes

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Type 2 Diabetes

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Others

7.4.1 Market Estimates & Forecast, 2020-2027

8. EMEA Blood Glucose Monitoring Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Diagnostic Centers

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Clinics

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Research centers

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Homecare Diagnostics

8.6.1 Market Estimates & Forecast, 2020-2027

9. EMEA Blood Glucose Monitoring Market, by Region

9.1 Introduction

9.2 Europe

9.2.1 Western Europe

9.2.1 Germany

9.2.2 France

9.2.3 U.K.

9.2.4 Italy

9.2.5 Spain

9.2.6 Rest of Western Europe

9.2.2 Eastern Europe

9.3 The Middle East & Africa

9.3.1 United Arab Emirates

9.3.2 Saudi Arabia

9.3.3 Oman

9.3.4 Kuwait

9.3.5 Qatar

9.3.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Arkay, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bayer Healthcare AG

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 F. Hoffmann-La Roche

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 LifeScan

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix

LIST OF TABLES

Table 1 Blood glucose monitoring Industry Synopsis, 2020-2027

Table 2 EMEA Blood glucose monitoring Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 EMEA Blood glucose monitoring Market by Country, 2020-2027, (USD Million)

Table 4 EMEA Blood glucose monitoring Market by Product Type, 2020-2027, (USD Million)

Table 5 EMEA Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 6 EMEA Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 7 Germany Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 8 Germany Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 9 Germany Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 10 France Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 11 France Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 12 France Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 13 United Kingdom Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 14 United Kingdom Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 15 United Kingdom Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 16 Italy Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 17 Italy Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 18 Italy Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 19 Spain Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 20 Spain Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 21 Spain Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 22 Rest of Western Europe Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 23 Rest of Western Europe Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 24 Rest of Western Europe Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 25 United Arab Emirates Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 26 United Arab Emirates Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 27 United Arab Emirates Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 28 Saudi Arabia Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 29 Saudi Arabia Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 30 Saudi Arabia Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 31 Oman Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 32 Oman Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 33 Oman Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 34 Kuwait Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 35 Kuwait Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 36 Kuwait Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 37 Qatar Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 38 Qatar Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 39 Qatar Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 40 Rest of the Middle East & Africa Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 41 Rest of the Middle East & Africa Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 42 Rest of the Middle East & Africa Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for EMEA Blood Glucose Monitoring Market

Figure 3 Segmentation Market Dynamics for Blood Glucose Monitoring Market

Figure 4 EMEA Blood Glucose Monitoring Market Share, by Product Type 2020

Figure 5 EMEA Blood Glucose Monitoring Market Share, by Application 2020

Figure 6 EMEA Blood Glucose Monitoring Market Share, by End User, 2020

Figure 7 EMEA Blood Glucose Monitoring Market Share, by Country, 2020

Figure 8 EMEA Blood Glucose Monitoring Market: Company Share Analysis, 2020 (%)

Figure 9 Abbott Laboratories.: Key Financials

Figure 10 Abbott Laboratories.: Segmental Revenue

Figure 11 Abbott Laboratories.: Geographical Revenue

Figure 12 Arkay, Inc.: Key Financials

Figure 13 Arkay, Inc.: Segmental Revenue

Figure 14 Arkay, Inc.: Geographical Revenue

Figure 15 Bayer Healthcare AG: Key Financials

Figure 16 Bayer Healthcare AG: Segmental Revenue

Figure 17 Bayer Healthcare AG: Geographical Revenue

Figure 18 F. Hoffmann-La Roche: Key Financials

Figure 19 F. Hoffmann-La Roche: Segmental Revenue

Figure 20 F. Hoffmann-La Roche: Geographical Revenue

Figure 21 LifeScan Diagnostics Inc.: Key Financials

Figure 22 LifeScan Diagnostics Inc.: Segmental Revenue

Figure 23 LifeScan Diagnostics Inc.: Geographical Revenue